Rare Disease Report
Patients & Caregivers

Treating Polycythemia Vera Patients Refractory to Hydroxyurea

SEPTEMBER 13, 2016
Srdan Verstovsek, MD, PhD

In a case study of a  45-year old man with polycythemia vera is refractory to hydroxyurea, Srdan Verstovsek, MD, PhD of the MD Anderson Cancer Center in Houston, Texas describes how ruxolitinib is a viable treatment option.

Copyright © RareDR 2013-2017 Rare Disease Communications. All Rights Reserved.